In 2023, the United States experienced the most significant increase in prescription drug spending (13.6%), totaling $89 billion. This was driven by higher utilization and the introduction of new, expensive specialty and biotech drugs. In 2024, other factors continue to drive costs and disrupt the pharmacy landscape, including the implementation of new business models, pharmacy benefit manager (PBM) practices, the rebate system, regulatory changes, advancements in provider status, and potential Federal Trade Commission (FTC) interventions.
Read the full article: Payment Disrupters and Opportunities: Key Trends That Impacted Pharmacy in 2024 //
Source: https://www.pharmacytimes.com/view/payment-disrupters-and-opportunities-key-trends-that-impacted-pharmacy-in-2024